169 related articles for article (PubMed ID: 20208555)
21. RUNX1T1/MTG8/ETO gene expression status in human t(8;21)(q22;q22)-positive acute myeloid leukemia cells.
Migas AA; Mishkova OA; Ramanouskaya TV; Ilyushonak IM; Aleinikova OV; Grinev VV
Leuk Res; 2014 Sep; 38(9):1102-10. PubMed ID: 24976338
[TBL] [Abstract][Full Text] [Related]
22. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
[TBL] [Abstract][Full Text] [Related]
23. CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations.
Francis J; Dharmadhikari AV; Sait SN; Deeb G; Wallace PK; Thompson JE; Wang ES; Wetzler M
Leuk Lymphoma; 2013 Jul; 54(7):1517-20. PubMed ID: 23193950
[TBL] [Abstract][Full Text] [Related]
24. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.
Tagoh H; Ingram R; Wilson N; Salvagiotto G; Warren AJ; Clarke D; Busslinger M; Bonifer C
EMBO J; 2006 Mar; 25(5):1070-80. PubMed ID: 16482219
[TBL] [Abstract][Full Text] [Related]
25. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.
Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J
Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032
[TBL] [Abstract][Full Text] [Related]
26. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
[TBL] [Abstract][Full Text] [Related]
27. In AML t(8;21) colony growth of both leukemic and residual normal progenitors is restricted to the CD34+, lineage-negative fraction.
Wittebol S; Raymakers R; van de Locht L; Mensink E; de Witte T
Leukemia; 1998 Nov; 12(11):1782-8. PubMed ID: 9823954
[TBL] [Abstract][Full Text] [Related]
28. Ectopic expression of PAX5 promotes maintenance of biphenotypic myeloid progenitors coexpressing myeloid and B-cell lineage-associated genes.
Anderson K; Rusterholz C; Månsson R; Jensen CT; Bacos K; Zandi S; Sasaki Y; Nerlov C; Sigvardsson M; Jacobsen SE
Blood; 2007 May; 109(9):3697-705. PubMed ID: 17218387
[TBL] [Abstract][Full Text] [Related]
29. Reversion of B cell commitment upon loss of Pax5 expression.
Mikkola I; Heavey B; Horcher M; Busslinger M
Science; 2002 Jul; 297(5578):110-3. PubMed ID: 12098702
[TBL] [Abstract][Full Text] [Related]
30. Isoforms of Pax5 and co-regulation of T- and B-cells associated genes influence phenotypic traits of ascetic cells causing Dalton's lymphoma.
Bharti B; Mishra R
Biochim Biophys Acta; 2011 Dec; 1813(12):2071-8. PubMed ID: 21854813
[TBL] [Abstract][Full Text] [Related]
31. Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML.
Lo MC; Peterson LF; Yan M; Cong X; Jin F; Shia WJ; Matsuura S; Ahn EY; Komeno Y; Ly M; Ommen HB; Chen IM; Hokland P; Willman CL; Ren B; Zhang DE
Blood; 2012 Aug; 120(7):1473-84. PubMed ID: 22740448
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.
Serrano E; Carnicer MJ; Lasa A; Orantes V; Pena J; Brunet S; Aventín A; Sierra J; Nomdedéu JF
Leuk Res; 2008 Jun; 32(6):944-53. PubMed ID: 18206229
[TBL] [Abstract][Full Text] [Related]
33. Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation.
Gibson SE; Dong HY; Advani AS; Hsi ED
Am J Clin Pathol; 2006 Dec; 126(6):916-24. PubMed ID: 17074681
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells.
Qu C; Li Z; Kang L; Wang Y; Dai H; Yin J; Chen G; Zhu M; Yao L; Xu T; Tian X; Xu Y; Chen J; Zhu X; Yu L; Wu D; Tang X
Bone Marrow Transplant; 2019 Jul; 54(7):1138-1140. PubMed ID: 30631098
[No Abstract] [Full Text] [Related]
35. Biphenotypic B-lymphoid/myeloid cells expressing low levels of Pax5: potential targets of BAL development.
Simmons S; Knoll M; Drewell C; Wolf I; Mollenkopf HJ; Bouquet C; Melchers F
Blood; 2012 Nov; 120(18):3688-98. PubMed ID: 22927250
[TBL] [Abstract][Full Text] [Related]
36. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
37. Chronic growth factor receptor signaling and lineage inappropriate gene expression in AML: the polycomb connection.
Ray D; Kwon SY; Ptasinska A; Bonifer C
Cell Cycle; 2013 Jul; 12(14):2159-60. PubMed ID: 23803734
[No Abstract] [Full Text] [Related]
38. Remission of acute myeloid leukemia with t(8;21) following CD19 CAR T-cells.
Danylesko I; Jacoby E; Yerushalmi R; Shem-Tov N; Besser MJ; Vernitsky H; Marcu-Malina V; Shimoni A; Avigdor A; Nagler A
Leukemia; 2020 Jul; 34(7):1939-1942. PubMed ID: 31980731
[No Abstract] [Full Text] [Related]
39. Pax5: a master regulator of B cell development and leukemogenesis.
Medvedovic J; Ebert A; Tagoh H; Busslinger M
Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
Firtina S; Sayitoglu M; Hatirnaz O; Erbilgin Y; Oztunc C; Cinar S; Yildiz I; Celkan T; Anak S; Unuvar A; Devecioglu O; Timur C; Aydogan G; Akcay A; Atay D; Turkkan E; Karaman S; Orhaner B; Sarper N; Deniz G; Ozbek U
Leuk Res; 2012 Jan; 36(1):87-92. PubMed ID: 21813177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
